GRAL Stock Analysis: Buy, Sell, or Hold?

GRAL - GRAIL, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$69.11
1.00 (1.47%) ▲
5d: +3.82%
30d: +15.38%
90d: +28.94%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Smart Money Accumulation

None View Scanner →

Strength: 5.6/10

Get Alerted When GRAL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: GRAL is currently trading at $69.11, which is considered extended relative to its 30-day fair value range of $59.79 to $68.69.

Technical Outlook: Technically, GRAL is showing sideways momentum. Immediate support is located at $60.00, while resistance sits at $71.41.

Market Sentiment: GRAL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $59.79 - $68.69
Company Quality Score 59/100 (HOLD)
Options IV Signal 19th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 66.7%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Options cheap (IV 19th percentile)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($66.00)

Trading Range Analysis

30-Day Trading Range $59.79 - $68.69
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$8.49 (12.3%)

Support & Resistance Levels

Support Level $60.00
Resistance Level $71.41
Current Trend Sideways
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -7.11
Wall Street Target $66.00 (-4.5%)
Revenue Growth (YoY) 28.1%
Profit Margin -253.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman SELL 61665 shares 2026-04-08
Robert P Ragusa SELL 123502 shares 2026-04-08
Aaron Freidin SELL 45806 shares 2026-04-08

Unlock Insider Activity

See real-time buying/selling by company executives for GRAL.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientific…
STRONG BUY
31 analysts
$599 64 BUY
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 65 BUY
DHR
Danaher Corporation
STRONG BUY
25 analysts
$242 64 BUY
GH
Guardant Health Inc
STRONG BUY
23 analysts
$144 61 BUY
NTRA
Natera Inc
STRONG BUY
21 analysts
$260 54 HOLD

Advanced GRAL Option Strategies

Professional options setups generated by AI based on today's GRAL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for GRAL

GRAL Technical Chart GRAL Price Prediction GRAL Earnings Date GRAL Investment Advisor GRAL Fair Price Analyzer GRAL Options Advisor GRAL Options Chain GRAL Options Analysis GRAL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals